PDB-code
Browse kinase entries (page 70 of 282)
First 66 67 68 PreviousLast74 73 72 Next| # | Kinase | Family | Group | PDB | Chain | (Alternate) Model | Orthosteric ligand | Organism | Details | File |
|---|---|---|---|---|---|---|---|---|---|---|
 | CSNK1D (CK1d) | CK1 | CK1 | 3uyt | D | 4-[1-cyclohexyl-4-(4-fluorophenyl)-1h-imidazol-5-yl]pyrimidin-2-amine | Human | Show |  | |
| CSNK1D (CK1d) | CK1 | CK1 | 3uzp | A | 4-[1-cyclohexyl-4-(4-fluorophenyl)-1h-imidazol-5-yl]pyrimidin-2-amine | Human | Show | | |
| CSNK1D (CK1d) | CK1 | CK1 | 3uzp | B | 4-[1-cyclohexyl-4-(4-fluorophenyl)-1h-imidazol-5-yl]pyrimidin-2-amine | Human | Show | | |
| CSNK1D (CK1d) | CK1 | CK1 | 4hgt | A | 2-{2-[(3,4-difluorophenoxy)methyl]-5-methoxypyridin-4-yl}-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one | Human | Show | | |
| CSNK1D (CK1d) | CK1 | CK1 | 4hgt | B | 2-{2-[(3,4-difluorophenoxy)methyl]-5-methoxypyridin-4-yl}-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one | Human | Show | | |
| CSNK1D (CK1d) | CK1 | CK1 | 4hnf | A | 3-[(3-chlorophenoxy)methyl]-1-(tetrahydro-2h-pyran-4-yl)-1h-pyrazolo[3,4-d]pyrimidin-4-amine | Human | Show | | |
| CSNK1D (CK1d) | CK1 | CK1 | 4hnf | B | 3-[(3-chlorophenoxy)methyl]-1-(tetrahydro-2h-pyran-4-yl)-1h-pyrazolo[3,4-d]pyrimidin-4-amine | Human | Show | | |
| CSNK1D (CK1d) | CK1 | CK1 | 4kb8 | A | A | 1-{4-[3-(4-fluorophenyl)-1-methyl-1h-pyrazol-4-yl]pyridin-2-yl}-n-methylmethanamine | Human | Show | |
| CSNK1D (CK1d) | CK1 | CK1 | 4kb8 | A | B | 1-{4-[3-(4-fluorophenyl)-1-methyl-1h-pyrazol-4-yl]pyridin-2-yl}-n-methylmethanamine | Human | Show | |
| CSNK1D (CK1d) | CK1 | CK1 | 4kb8 | B | A | n-benzyl-4-(pyridin-3-yl)pyrimidin-2-amine | Human | Show | |
| CSNK1D (CK1d) | CK1 | CK1 | 4kb8 | B | B | n-benzyl-4-(pyridin-3-yl)pyrimidin-2-amine | Human | Show | |
| CSNK1D (CK1d) | CK1 | CK1 | 4kb8 | C | A | 1-{4-[3-(4-fluorophenyl)-1-methyl-1h-pyrazol-4-yl]pyridin-2-yl}-n-methylmethanamine | Human | Show | |
| CSNK1D (CK1d) | CK1 | CK1 | 4kb8 | C | B | 1-{4-[3-(4-fluorophenyl)-1-methyl-1h-pyrazol-4-yl]pyridin-2-yl}-n-methylmethanamine | Human | Show | |
| CSNK1D (CK1d) | CK1 | CK1 | 4kb8 | D | A | n-benzyl-4-(pyridin-3-yl)pyrimidin-2-amine | Human | Show | |
| CSNK1D (CK1d) | CK1 | CK1 | 4kb8 | D | B | n-benzyl-4-(pyridin-3-yl)pyrimidin-2-amine | Human | Show | |
| CSNK1D (CK1d) | CK1 | CK1 | 4kba | A | A | 9-[3-(4-fluorophenyl)-1-methyl-1h-pyrazol-4-yl]-2,3,4,5-tetrahydropyrido[2,3-f][1,4]oxazepine | Human | Show | |
| CSNK1D (CK1d) | CK1 | CK1 | 4kba | A | B | 9-[3-(4-fluorophenyl)-1-methyl-1h-pyrazol-4-yl]-2,3,4,5-tetrahydropyrido[2,3-f][1,4]oxazepine | Human | Show | |
| CSNK1D (CK1d) | CK1 | CK1 | 4kba | B | A | 9-[3-(4-fluorophenyl)-1-methyl-1h-pyrazol-4-yl]-2,3,4,5-tetrahydropyrido[2,3-f][1,4]oxazepine | Human | Show | |
| CSNK1D (CK1d) | CK1 | CK1 | 4kba | B | B | 9-[3-(4-fluorophenyl)-1-methyl-1h-pyrazol-4-yl]-2,3,4,5-tetrahydropyrido[2,3-f][1,4]oxazepine | Human | Show | |
| CSNK1D (CK1d) | CK1 | CK1 | 4kba | C | A | 9-[3-(4-fluorophenyl)-1-methyl-1h-pyrazol-4-yl]-2,3,4,5-tetrahydropyrido[2,3-f][1,4]oxazepine | Human | Show | |
| CSNK1D (CK1d) | CK1 | CK1 | 4kba | C | B | 9-[3-(4-fluorophenyl)-1-methyl-1h-pyrazol-4-yl]-2,3,4,5-tetrahydropyrido[2,3-f][1,4]oxazepine | Human | Show | |
| CSNK1D (CK1d) | CK1 | CK1 | 4kba | D | A | 9-[3-(4-fluorophenyl)-1-methyl-1h-pyrazol-4-yl]-2,3,4,5-tetrahydropyrido[2,3-f][1,4]oxazepine | Human | Show | |
| CSNK1D (CK1d) | CK1 | CK1 | 4kba | D | B | 9-[3-(4-fluorophenyl)-1-methyl-1h-pyrazol-4-yl]-2,3,4,5-tetrahydropyrido[2,3-f][1,4]oxazepine | Human | Show | |
| CSNK1D (CK1d) | CK1 | CK1 | 4kbc | A | A | {4-[3-(4-fluorophenyl)-1h-pyrazol-4-yl]pyridin-2-yl}methanol | Human | Show | |
| CSNK1D (CK1d) | CK1 | CK1 | 4kbc | A | B | {4-[3-(4-fluorophenyl)-1h-pyrazol-4-yl]pyridin-2-yl}methanol | Human | Show | |
| CSNK1D (CK1d) | CK1 | CK1 | 4kbc | B | A | {4-[3-(4-fluorophenyl)-1h-pyrazol-4-yl]pyridin-2-yl}methanol | Human | Show | |
| CSNK1D (CK1d) | CK1 | CK1 | 4kbc | B | B | {4-[3-(4-fluorophenyl)-1h-pyrazol-4-yl]pyridin-2-yl}methanol | Human | Show | |
| CSNK1D (CK1d) | CK1 | CK1 | 4kbk | A | A | (3s)-3-{4-[3-(4-fluorophenyl)-1-methyl-1h-pyrazol-4-yl]pyridin-2-yl}morpholine | Human | Show | |
| CSNK1D (CK1d) | CK1 | CK1 | 4kbk | A | B | (3s)-3-{4-[3-(4-fluorophenyl)-1-methyl-1h-pyrazol-4-yl]pyridin-2-yl}morpholine | Human | Show | |
| CSNK1D (CK1d) | CK1 | CK1 | 4kbk | B | A | (3s)-3-{4-[3-(4-fluorophenyl)-1-methyl-1h-pyrazol-4-yl]pyridin-2-yl}morpholine | Human | Show | |
| CSNK1D (CK1d) | CK1 | CK1 | 4kbk | B | B | (3s)-3-{4-[3-(4-fluorophenyl)-1-methyl-1h-pyrazol-4-yl]pyridin-2-yl}morpholine | Human | Show | |
| CSNK1D (CK1d) | CK1 | CK1 | 4kbk | C | A | (3s)-3-{4-[3-(4-fluorophenyl)-1-methyl-1h-pyrazol-4-yl]pyridin-2-yl}morpholine | Human | Show | |
| CSNK1D (CK1d) | CK1 | CK1 | 4kbk | C | B | (3s)-3-{4-[3-(4-fluorophenyl)-1-methyl-1h-pyrazol-4-yl]pyridin-2-yl}morpholine | Human | Show | |
| CSNK1D (CK1d) | CK1 | CK1 | 4kbk | D | A | (3s)-3-{4-[3-(4-fluorophenyl)-1-methyl-1h-pyrazol-4-yl]pyridin-2-yl}morpholine | Human | Show | |
| CSNK1D (CK1d) | CK1 | CK1 | 4kbk | D | B | (3s)-3-{4-[3-(4-fluorophenyl)-1-methyl-1h-pyrazol-4-yl]pyridin-2-yl}morpholine | Human | Show | |
| CSNK1D (CK1d) | CK1 | CK1 | 4tn6 | A | A | 4-{4-(4-fluorophenyl)-1-[1-(1,2-oxazol-3-ylmethyl)piperidin-4-yl]-1h-imidazol-5-yl}pyrimidin-2-amine | Human | Show | |
| CSNK1D (CK1d) | CK1 | CK1 | 4tn6 | A | B | 4-{4-(4-fluorophenyl)-1-[1-(1,2-oxazol-3-ylmethyl)piperidin-4-yl]-1h-imidazol-5-yl}pyrimidin-2-amine | Human | Show | |
| CSNK1D (CK1d) | CK1 | CK1 | 4tn6 | B | A | - | Human | Show | |
| CSNK1D (CK1d) | CK1 | CK1 | 4tn6 | B | B | - | Human | Show | |
| CSNK1D (CK1d) | CK1 | CK1 | 4tw9 | A | A | octyl beta-l-talopyranoside | Human | Show | |
| CSNK1D (CK1d) | CK1 | CK1 | 4tw9 | A | B | octyl beta-l-talopyranoside | Human | Show | |
| CSNK1D (CK1d) | CK1 | CK1 | 4tw9 | B | A | n-(2,2-difluoro-5h-[1,3]dioxolo[4,5-f]benzimidazol-6-yl)-2-{[2-(trifluoromethoxy)benzoyl]amino}-1,3-thiazole-4-carboxamide | Human | Show | |
| CSNK1D (CK1d) | CK1 | CK1 | 4tw9 | B | B | n-(2,2-difluoro-5h-[1,3]dioxolo[4,5-f]benzimidazol-6-yl)-2-{[2-(trifluoromethoxy)benzoyl]amino}-1,3-thiazole-4-carboxamide | Human | Show | |
| CSNK1D (CK1d) | CK1 | CK1 | 4twc | A | A | 2-{[2-(trifluoromethoxy)benzoyl]amino}-n-[6-(trifluoromethyl)-1h-benzimidazol-2-yl]-1,3-thiazole-4-carboxamide | Human | Show | |
| CSNK1D (CK1d) | CK1 | CK1 | 4twc | A | B | 2-{[2-(trifluoromethoxy)benzoyl]amino}-n-[6-(trifluoromethyl)-1h-benzimidazol-2-yl]-1,3-thiazole-4-carboxamide | Human | Show | |
| CSNK1D (CK1d) | CK1 | CK1 | 4twc | B | A | 2-{[2-(trifluoromethoxy)benzoyl]amino}-n-[6-(trifluoromethyl)-1h-benzimidazol-2-yl]-1,3-thiazole-4-carboxamide | Human | Show | |
| CSNK1D (CK1d) | CK1 | CK1 | 4twc | B | B | 2-{[2-(trifluoromethoxy)benzoyl]amino}-n-[6-(trifluoromethyl)-1h-benzimidazol-2-yl]-1,3-thiazole-4-carboxamide | Human | Show | |
| CSNK1D (CK1d) | CK1 | CK1 | 5ih4 | A | A | - | Human | Show | |
| CSNK1D (CK1d) | CK1 | CK1 | 5ih4 | A | B | - | Human | Show | |
| CSNK1D (CK1d) | CK1 | CK1 | 5ih4 | A | C | - | Human | Show | |
